It was great to do this podcast. Persistent #viruses - and many bacteria, fungi and even parasite pathogens - directly hijack our #mitochondria. They can hack and distort human gene signaling that controls senescence & inflammaging. This knowledge is huge for longevity treatments
Great to be featured last night on @WCVB along with amazing PolyBio funder & collaborator Steve Pagliuca. We are working hard to validate novel #diagnostic tests and treatments for the millions of patients around the world suffering from Long COVID & Chronic Lyme disease @pagsceltics@JessicaBrownTVwcvb.com/article/former-celt…
Persistent viral, bacterial, parasite & other #infections are increasingly implicated in chronic diseases and aging
We’ve united the top scientists, biotech innovators, and other stakeholders working to study & treat these infections into a 3-day Summit.
Come watch the talks virtually at the link below! 👇
We’re pleased to announce the inaugural PolyBio Convergence Summit will take place this November 18 to 20.
Presentations will explore the latest advances in persistent infections and their emerging roles in conditions such as Long COVID, chronic Lyme disease, multiple sclerosis, Alzheimer’s, and aging. Discussions will focus on the practical challenges that must be addressed to translate these discoveries into validated diagnostics, clinical trials, and effective therapies.
Add the virtual schedule to your calendar here: calendar.google.com/calendar…
Breaking: PolyBio-Supported Preprint Finds Persistently Activated Virus-Specific T cells in a Subset of People with Long COVID
👉🏻Virus-specific immune cells show signs of ongoing stimulation and impaired function in a subset of people with Long COVID, offering a potential way to guide targeted clinical trials
1/
Breaking: Steve and Judy Pagliuca and Governor Maura Healey Accelerate Major Effort to Deliver Treatments for Long COVID $15 million raised by a coalition of donors to advance diagnostics and clinical trials for Long COVID; with the infrastructure expanding into chronic Lyme disease
1/
In collaboration with the LA Times, Drs. Amy Proal and Tim Henrich discussed the latest tissue-based research approaches to investigate underlying drivers of Long COVID.
“If we’re really going to understand what’s happening and where [SARS-CoV-2] is persisting… we really need to understand what’s happening in these tissues,” said Henrich, co-Principal Investigator in USCF’s PolyBio-supported LIINC tissue program.
“We’re also trying to develop non-invasive means… using PET imaging, to look at different immune activation states, or maybe even look for the virus itself… These studies are currently in progress so we don’t have to put people through these biopsies, or ask for invasive procedures when we can do this in a non-invasive state.”
Breaking: New Study Reveals Substantial Tissue-Level Immune Dysfunction Near Persistent Viral Reservoirs in Long COVID
👉🏻PolyBio-funded UCSF research finds persistent SARS-CoV-2 RNA alongside an altered gut immune response that may impair viral clearance 1/
It's madness that most people in the healthspan-extension space do little to control the activity of #viral, bacterial, #parasite and other pathogens that can hack their bodies over time.
Come listen to me talk at the Liberty Hotel next Thurs where I will discuss how to change this by optimizing anti-pathogen treatment approaches!
eventbrite.com/e/health-inno…
7/ Additional work is investigating whether SARS-CoV-2 persists within vascular tissue itself, potentially sustaining chronic inflammation and cardiovascular risk.
5/ A consistent vascular signal emerged across multiple presentations: Long COVID is associated with endothelial dysfunction, thromboinflammation, platelet abnormalities, and microvascular issues.
4/ Sean Miller (Yale) showed that Long COVID patients undergoing multimodal retinal imaging have abnormal protein deposition. Retinal organoid models exposed to SARS-CoV-2 spike develop amyloid-beta and alpha-synuclein aggregation: both lines of evidence suggesting potential long-term neurodegenerative risk associated with SARS-CoV-2 infection.
3/ On the neuroimmune front, Michael VanElzakker (Harvard) reported neuroinflammation in the Long COVID brain, and a roughly fourfold increased prevalence of brain-derived p-tau217 (an Alzheimer's-risk marker) in Long COVID vs. controls.
2/ This is now arguably the strongest mechanistic working model in the field, and the disease mechanism that the first phase of our VIPER diagnostics program is testing at scale.
Check out these talk summaries from our recent PolyBio Symposium👇
Highlights include that four groups — Tim Henrich (UCSF), Marcus Buggert (Karolinska), Nicolas Huot (Institut Pasteur), and Esen Sefik (Yale) — presented different lines of evidence (human gut biopsies, non-human primate models, humanized mice) all pointing to the same conclusion: SARS-CoV-2 persists in #LongCovid gut tissue and adjacent lymphoid structures, and that persistence drives ongoing immune dysregulation.